Humana, Inc. Hits New 52-Week High of $398.49, Showcasing Strong Growth

Humana, Inc. has reached a significant milestone by hitting a new 52-week high of USD 398.49 on June 30, 2026. This achievement underscores the company's strong performance within the healthcare services industry, where it operates as a large-cap entity with a market capitalization of USD 32,156 million. Over the past year, Humana's stock has demonstrated a performance increase of 13.71%, although it trails behind the S&P 500's performance of 20.86%. The company's price-to-earnings (P/E) ratio stands at 27.00, reflecting its valuation relative to earnings. Additionally, Humana offers a dividend yield of 1.60%, providing a return to shareholders. Financial metrics indicate a solid position, with a return on equity of 6.81% and a price-to-book ratio of 1.82. The company's debt equity ratio is notably low at -0.42, suggesting a conservative approach to leverage. Overall, Humana's recent price achievement highlights its ongoing presence and performance in the competitive healthcare services market.